| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 2405-2412, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
M DiGirolamo, FD Newby and J Lovejoy
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303.
Estimates of the quantitative contribution of adipose tissue to whole- body glucose metabolism, previously reported as 1-3%, have been revised to be on the order of 10-30%. These revised estimates come, in part, from a recognition that adipose tissue uses glucose to produce lactate and pyruvate, in addition to CO2 and triglycerides. Lactate production by adipose tissue is modulated in vitro by changes in glucose, insulin, and epinephrine concentrations. In vivo, lactate production is regulated acutely by the animal's nutritional state (fed or fasted) and chronically by the degree of obesity. A strong positive correlation exists between rat fat cell size and relative conversion of glucose to lactate (r = 0.89, P less than 0.001). Diabetes is also associated with markedly increased lactate production in adipocytes. Fat cells from obese or diabetic rats (or humans) can metabolize to lactate as much as 50-70% of the glucose taken up. From these recent studies, a picture is emerging in which the adipose organ may provide lactate for hepatic gluconeogenesis during fasting, and also lactate for hepatic glycogen synthesis after food ingestion. Modulation of adipocyte lactate production and contribution of adipose tissue lactate to the body's fuel economy in physiological and pathological states are the focus of this review.
This article has been cited by other articles:
|
|
 |
|
  A. Nareika, L. He, B. A. Game, E. H. Slate, J. J. Sanders, S. D. London, M. F. Lopes-Virella, and Y. Huang Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-{kappa}B transcriptional activities Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E534 - E542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ferrari, M. Arnold, R. D. Carr, W. Langhans, G. Pacini, T. B. Bodvarsdottir, and D. X. Gram Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1027 - R1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Arsenijevic, E. Gallmann, W. Moses, T. Lutz, C. Erlanson-Albertsson, and W. Langhans Enterostatin decreases postprandial pancreatic UCP2 mRNA levels and increases plasma insulin and amylin Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E40 - E45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bogacka, H. Xie, G. A. Bray, and S. R. Smith Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo Diabetes, May 1, 2005; 54(5): 1392 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lange Role of microvillar cell surfaces in the regulation of glucose uptake and organization of energy metabolism Am J Physiol Cell Physiol, January 1, 2002; 282(1): C1 - C26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Py, K. Lambert, A. Perez-Martin, E. Raynaud, C. Prefaut, and J. Mercier Impaired sarcolemmal vesicle lactate uptake and skeletal muscle MCT1 and MCT4 expression in obese Zucker rats Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1308 - E1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Sandqvist, J. W. Eriksson, and P.-A. E. Jansson Increased Lactate Release per Fat Cell in Normoglycemic First-Degree Relatives of Individuals With Type 2 Diabetes Diabetes, October 1, 2001; 50(10): 2344 - 2348. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. N. Fain, N. A. Del Mar, C. A. Meade, A. Reiner, and D. Goldowitz Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation Hum. Mol. Genet., January 1, 2001; 10(2): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Silberbauer, D. M. Surina-Baumgartner, M. Arnold, and W. Langhans Prandial lactate infusion inhibits spontaneous feeding in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R646 - R653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lombardi, R. Fabris, F. Bassetto, R. Serra, A. Leturque, G. Federspil, J. Girard, and R. Vettor Hyperlactatemia reduces muscle glucose uptake and GLUT-4 mRNA while increasing (E1alpha )PDH gene expression in rat Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E922 - E929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Mueller, F. M. Gregoire, K. L. Stanhope, C. V. Mobbs, T. M. Mizuno, C. H. Warden, J. S. Stern, and P. J. Havel Evidence That Glucose Metabolism Regulates Leptin Secretion from Cultured Rat Adipocytes Endocrinology, February 1, 1998; 139(2): 551 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tozzo, L. Gnudi, and B. B. Kahn Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter Endocrinology, April 1, 1997; 138(4): 1604 - 1611. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
